News
A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...
Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.
Amy Schumer shares on Instagram that Mounjaro worked wonders for her weight loss and perimenopause symptoms, unlike Ozempic, ...
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
Under Sorensen, the company develops its first GLP-1 drug, a precursor to Ozempic and Wegovy. Liraglutide, a GLP-1 product for treatment of type 2 diabetes, enters phase 3 trials. Novo Nordisk ...
A government crackdown on cheaper copies of Ozempic and similar diabetes and weight ... dosages slightly different from the standard, FDA-approved amounts or including additives such as vitamins ...
Doctors have warned of some hidden and potentially lethal side effects of using Ozempic amid the increasing popularity of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results